OFI Advisors’s West Pharmaceutical WST Stock Holding History

OFI Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$231K	Sell	4,275 -10,060	-70%	-$586K	0.01%	1141
2015 Q2	$833K	Buy	14,335 +256	+2%	+$14.3K	0.05%	481
2015 Q1	$848K	Buy	14,079 +1,414	+11%	+$75.4K	0.05%	456
2014 Q4	$674K	Sell	12,665 -1,953	-13%	-$97.7K	0.04%	524
2014 Q3	$654K	Sell	14,618 -644	-4%	-$27.4K	0.05%	483
2014 Q2	$644K	Buy	15,262 +2,133	+16%	+$91.3K	0.05%	501
2014 Q1	$578K	Buy	13,129 +1,882	+17%	+$88.6K	0.04%	502
2013 Q4	$552K	Buy	11,247 +551	+5%	+$25.8K	0.04%	498
2013 Q3	$440K	Buy	10,696 +80	+0.8%	+$3.05K	0.04%	514
2013 Q2	$373K	Buy	+10,616	New	+$349K	0.04%	517

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

OFI Advisors's WST Position: Q3 2015 in Review

OFI Advisors reduced its West Pharmaceutical (WST) stake by 70% in Q3 2015, selling an estimated $586K and leaving 4,275 shares worth $231K. The position accounts for 0.01% of the portfolio, ranked #1141.

OFI Advisors first reported a position in WST in Q2 2013 and has held it in 10 quarters since. The position peaked at $848K in Q1 2015. 247 funds tracked by Wall St. Rank hold WST as of Q3 2015.

OFI Advisors held 4,275 shares of West Pharmaceutical worth $231K as of Q3 2015.
OFI Advisors sold 10,060 West Pharmaceutical shares in Q3 2015, an estimated $586K.
West Pharmaceutical made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1141 holding.
OFI Advisors first reported a position in West Pharmaceutical in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's West Pharmaceutical position peaked at $848K in Q1 2015.
247 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.